Number of the records: 1  

receptor inzulínový

  1. SYSd011972
    LBL
      
    00000cz--a2200000o--4500
    005
      
    20250606213834.6
    008
      
    920503|||anznnbabn-----------|-a|a------
    040
      
    $b slo $a DNLM $d BA006
    065
      
    $a D08.811.913.696.620.682.725.400.200
    065
      
    $a D12.776.476.568.400.200
    065
      
    $a D12.776.543.750.630.484
    065
      
    $a D12.776.543.750.750.580.300
    066
      
    $a 01 $c 03
    150
      
    $a receptor inzulínový $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo
    450
      
    $w v $a Insulin Receptor $2 eng
    450
      
    $w v $a Insulin Receptor alpha Subunit $2 eng
    450
      
    $w v $a Insulin Receptor beta Subunit $2 eng
    450
      
    $w v $a Insulin Receptor Protein-Tyrosine Kinase $2 eng
    450
      
    $w v $a receptor inzulínu $2 slo
    450
      
    $w v $a receptor pre inzulín $2 slo
    450
      
    $w v $a alfa podjednotka inzulínového receptora $2 slo
    450
      
    $w v $a beta podjednotka inzulínového receptora $2 slo
    450
      
    $w v $a proteínkináza tyrozínová, inzulínového receptora $2 slo
    450
      
    $w v $a proteín-tyrozínová kináza inzulínového receptora $2 slo
    450
      
    $w v $a proteíntyrozínkináza inzulínového receptora $2 slo
    550
      
    $7 sllk_us_auth*d007328 $Y Insulin $w b $a inzulín
    550
      
    $7 sllk_us_auth*d056731 $Y Donohue Syndrome $w p $a Donohueov syndróm
    550
      
    $7 sllk_us_auth*d056731 $Y Donohue Syndrome $w b $a Donohueov syndróm
    665
      
    $a 2000(1977); for INSULIN RECEPTOR PROTEIN-TYROSINE KINASE use RECEPTOR, INSULIN (NM) 1983-1993 $2 eng
    665
      
    $a Insulin (1966-1976) $2 eng
    665
      
    $a Receptors, Drug (1968-1976) $2 eng
    665
      
    $a Receptors, Endogenous Substances (1973-1976) $2 eng
    680
    9-
    $i A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. $2 eng
    750
    -2
    $a Receptor, Insulin $2 eng
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.